ArticleClinical ophthalmology (Auckland, N.Z.)2025

Quantitative Assessment of En‑face OCT‑Derived Minimum Intensity Fluid Changes Following Ranibizumab Biosimilar Therapy in Macular Neovascularization Secondary to nAMD and PCV.

Jay Umed Sheth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.